NCT05645952

Brief Summary

In this study, the investigators evaluated the association between various measures of adiposity \[BMI and waist circumference (WC)\] and clinical outcomes in Asian patients with dilated cardimyopathy, using a nationwide population based cohort.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

2.3 years

First QC Date

December 2, 2022

Last Update Submit

July 26, 2023

Conditions

Dilated CardiomyopathyObesityCardiovascular Morbidity

Keywords

Dilated CardiomyopathyObesity paradox

Outcome Measures

Primary Outcomes (1)

  • Composite of Outcomes

    Death + CV hospitalization + Fatal arrest event

    5 years

Secondary Outcomes (3)

  • Death

    5 years

  • CV hospitalization

    5 years

  • Fatal arrest event

    5 years

Study Arms (1)

Patients diagnosed with DCMP during study period

Patients newly diagnosed with DCMP between January 2015 and December 2020

Other: Clinical follow up of hypertrophic cardiomyopathy

Interventions

Clinical follow up of hypertrophic cardiomyopathyOTHER

Patients diagnosed with hypertrophic cardiomyopathy during study period

Also known as: Clinical diasgnosis of hypertrophic cardiomyopathy
Patients diagnosed with DCMP during study period

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We included patients newly diagnosed with DCMP between January 2015 and December 2020. Patients aged \<20 years, those who were already diagnosed with DCMP before 2015, and those with coronary artery disease, valvular heart disease, congenital heart disease, hypothyroidism, hyperthyroidism, and the cancer were excluded from the analysis. The follow-up period was defined as the time from the index date (date of diagnosis) to each outcome event, date of death, or end of the study period (December 31, 2020), whichever came first.

You may qualify if:

  • Patients newly diagnosed with DCMP between January 2015 and December 2020.

You may not qualify if:

  • Patients aged \<20 years
  • Patients already diagnosed with DCMP before 2015
  • Patients with coronary artery disease, valvular heart disease, congenital heart disease, hypothyroidism, hyperthyroidism, and the cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ajou University School of Medicine

Suwon, Gyeonggi-do, 16499, South Korea

RECRUITING

Related Publications (3)

  • Kim MS, Kim WJ, Khera AV, Kim JY, Yon DK, Lee SW, Shin JI, Won HH. Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies. Eur Heart J. 2021 Sep 7;42(34):3388-3403. doi: 10.1093/eurheartj/ehab454.

    PMID: 34333589BACKGROUND

  • Castleberry CD, Jefferies JL, Shi L, Wilkinson JD, Towbin JA, Harrison RW, Rossano JW, Pahl E, Lee TM, Addonizio LJ, Everitt MD, Godown J, Mahgerefteh J, Rusconi P, Canter CE, Colan SD, Kantor PF, Razoky H, Lipshultz SE, Miller TL. No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. JACC Heart Fail. 2018 Mar;6(3):222-230. doi: 10.1016/j.jchf.2017.11.015. Epub 2018 Feb 7.

    PMID: 29428438BACKGROUND

  • Rayner JJ, Peterzan MA, Clarke WT, Rodgers CT, Neubauer S, Rider OJ. Obesity modifies the energetic phenotype of dilated cardiomyopathy. Eur Heart J. 2021 Sep 20;43(9):868-77. doi: 10.1093/eurheartj/ehab663. Online ahead of print.

    PMID: 34542592BACKGROUND

MeSH Terms

Conditions

Cardiomyopathy, DilatedObesity

Condition Hierarchy (Ancestors)

CardiomegalyHeart DiseasesCardiovascular DiseasesCardiomyopathiesLaminopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Kwang-No LEE

    Ajou University School of Medicine

    STUDY CHAIR

Central Study Contacts

Kwang-No LEE

CONTACT

+82-9286-1123knlee81@ajou.ac.kr

Moon-Seung SOH

CONTACT

+82-10-5386-7701mssoh7701@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 2, 2022

First Posted

December 12, 2022

Study Start

July 1, 2022

Primary Completion

October 31, 2024

Study Completion

December 31, 2024

Last Updated

July 27, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations

KR(1)